The global stem cell industry is expanding, as rapid technological and clinical advances reveal new uses and platforms that are reshaping the landscape of regenerative medicine. Already being explored as treatments for osteoarthritis and joint repair, chronic wounds and tissue injuries, hair restoration and skin rejuvenation, and inflammation-related disorders, stem cells and exosomes are increasingly at the forefront of exciting new medical breakthroughs.
Scientists in Zurich have shown that stem cell transplants in mice can reverse stroke damage by regenerating neurons, restoring motor functions, and even repairing blood vessels — treatments could soon be adapted for humans. Japan has approved ground-breaking stem-cell treatments for Parkinson’s and severe heart failure, with the therapies expected to reach patients within months. And around the world, stem cells and exosomes are being explored as possible solutions for conditions ranging from diabetes to multiple sclerosis to autism and beyond.
